Catalyst Consultants, Rickmansworth, UK.
Faculty of Life Sciences & Medicine, King's College, London, UK.
J Comp Eff Res. 2019 Nov;8(15):1317-1326. doi: 10.2217/cer-2019-0088. Epub 2019 Sep 17.
To assess the comparative effectiveness of two hypoallergenic formulae in managing cow's milk allergic infants. This study retrospectively analyzed the case records of 940 formula-fed cow's milk allergic infants in the UK extracted from The Health Improvement Network database. At 24 months after starting a formula, 77% of infants fed an extensively hydrolyzed casein formula supplemented with GG (eHCF LGG; n = 470) were estimated to have been successfully managed compared with 63% of matched infants who were fed an extensively hydrolyzed whey formula (eHWF; n = 470; p < 0.001). Additionally, significantly more eHWF-fed infants were estimated to be experiencing gastrointestinal symptoms, eczema and asthma (7.1 vs 3.1%; p < 0.02) at 24 months. First-line management of newly diagnosed cow's milk allergic infants with eHCF LGG may slow down the allergic march seen in cow's milk allergic children.
评估两种低敏配方对管理牛奶过敏婴儿的效果。本研究回顾性分析了英国健康改善网络数据库中提取的 940 名配方奶喂养的牛奶过敏婴儿的病例记录。在开始使用配方奶 24 个月后,估计有 77%接受富含长双歧杆菌 GG 的深度水解酪蛋白配方(eHCF LGG;n=470)喂养的婴儿得到了成功管理,而接受深度水解乳清配方(eHWF;n=470)喂养的匹配婴儿中,这一比例为 63%(p<0.001)。此外,在 24 个月时,估计 eHWF 喂养的婴儿更容易出现胃肠道症状、湿疹和哮喘(7.1%比 3.1%;p<0.02)。对于新诊断为牛奶过敏的婴儿,使用 eHCF LGG 进行一线管理可能会减缓牛奶过敏儿童中过敏进展的速度。